Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-13-036656
Filing Date
2013-06-26
Accepted
2013-06-26 14:54:06
Documents
7
Period of Report
2013-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v348655_6k.htm 6-K 9046
2 GRAPHIC tlogo.jpg GRAPHIC 6713
3 EXHIBIT 99.1 v348655_ex99-1.htm EX-99.1 513393
4 GRAPHIC image_002.jpg GRAPHIC 1647
5 GRAPHIC image_004.gif GRAPHIC 2024
6 GRAPHIC image_005.gif GRAPHIC 1950
7 GRAPHIC image_006.gif GRAPHIC 1928
  Complete submission text file 0001144204-13-036656.txt   543699
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 13934240
SIC: 2834 Pharmaceutical Preparations